OGSIVEO, a drug marketed by Springworks, has fifteen patents and sixty-four patent family members across forty-five countries. The generic ingredient is nirogacestat hydrobromide, supplied by one company. Additional information is available on DrugPatentWatch.
Cyber expert urges against ‘panic’ over NHS data leak
The founding CEO of the UK’s National Cyber Security Centre, Ciaran Martin, has advised against panic after a ransomware group posted thousands of patient records